Synthetic Biologics (SYN) Misses Q2 EPS by 8c

Synthetic Biologics (NYSE: SYN) reported Q2 EPS of ($0.19), $0.08 worse than the analyst estimate of ($0.11).

For earnings history and earnings-related data on Synthetic Biologics (SYN) click here.

You May Also Be Interested In

• Klarna shares tumble on weak full-year revenue guidance
• Xylem names Andrea van der Berg as CFO, effective Sept. 2026
• Baidu slips as Q2 results miss estimates despite growth in AI cloud business